Evidence map›Paper›PMID 41065929›Full record

ArticleThe international journal of cardiovascular imaging2025

Assessment of aortic and mitral valve regurgitation volumes by cardiovascular magnetic resonance in participants without valvular heart disease in the Hamburg City Health Study population.

Katharina A Riedl, Georgios Koliopanos, Jan N Albrecht, Ersin Cavus, Jan-Per Wenzel, Martin Sinn, Bjoern P Schoennagel, Gunnar K Lund, Gerhard Adam, Paulus Kirchhof and 3 more

Abstract read
In one paragraph

Article in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Katharina A RiedlDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. k.riedl@uke.de.ORCID http://orcid.org/0000-0001-5956-0051
Georgios KoliopanosCardio-CARE, Medizincampus Davos, Davos, Switzerland.ORCID http://orcid.org/0000-0003-0667-6178
Jan N AlbrechtDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ersin CavusDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jan-Per WenzelDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Martin SinnDepartment of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bjoern P SchoennagelDepartment of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Gunnar K LundDepartment of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Gerhard AdamDepartment of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Paulus KirchhofDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stefan BlankenbergDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Andreas ZieglerDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0002-8386-5397
Kai MuellerleileDepartment of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An assessment of currently available cardiovascular magnetic resonance (CMR) methods to quantify aortic (AR) and mitral regurgitation (MR) in a large, population-based setting is lacking. The aim of this study was to evaluate CMR-based AR and MR quantification methods by quantifying AR and MR in participants without valvular heart disease in the population-based Hamburg City Health Study (HCHS). CMR was performed at 3T in the HCHS population. Aortic valve regurgitation volume (CMR-ARV) was directly obtained from 2D transaortic flow measurements. Mitral valve regurgitation volumes (CMR-MRV) were calculated by subtracting aortic forward flow volumes by Flow CMR from left ventricular stroke volumes by Cine CMR as currently recommended and by a method to account for potential confounding effects of AR on MR calculations (CMR-MRV

Indexed as

Aortic ValveAortic Valve InsufficiencyMagnetic Resonance Imaging, CineMitral ValveMitral Valve InsufficiencyAgedFemaleGermanyHemodynamicsHumansMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsSeverity of Illness IndexAortic regurgitationCardiovascular magnetic resonanceEchocardiographyFlow CMRMitral regurgitation

Identifiers

PMID41065929
PMCPMC12678579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.